title: The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.
abstract: Strategies are needed for drafting miRNA patent applications, in light of the existing patent landscape and genomic patent strategies of the past decades.
authors.affiliation: Cooley LLP, Washington, DC, USA. bweissmcleod@cooley.com
authors.forename: Bonnie W
authors.initials: BW
authors.lastname: McLeod
authors.forename: Mark L
authors.initials: ML
authors.lastname: Hayman
authors.forename: Angela L
authors.initials: AL
authors.lastname: Purcell
authors.forename: Joshua S
authors.initials: JS
authors.lastname: Marcus
authors.forename: Erich
authors.initials: E
authors.lastname: Veitenheimer
mesh_terms: D000818:Animals; D001709:Biotechnology / Q000331:legislation & jurisprudence*; D030881:Disclosure; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D020224:Expressed Sequence Tags; D006801:Humans; D018973:Intellectual Property; D035683:MicroRNAs; D010330:Patents as Topic
chemical_list: D035683:MicroRNAs